Back to Search
WINSTON YUNG, MD
MD
Pediatrics Physician
NPI: 1649339243Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
A74156(CA)
Research & Publications (20)
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
PMID 10944597·Br J Cancer·2000
3-trial
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
PMID 19562255·J Neurooncol·2010
3-trial
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
PMID 19293394·Neuro Oncol·2009
3-trial
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas.
PMID 19671762·Mol Cancer Ther·2009
8-other
L-DOPA neurotoxicity is mediated by up-regulation of DMT1-IRE expression.
PMID 19240805·PLoS One·2009
7-preclinical
The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes.
PMID 19027283·J Nutr Biochem·2009
7-preclinical
Electrophysiological effects of neurotensin on globus pallidus neurons of 6-hydroxydopamine-lesioned rats.
PMID 19202346·Neurosignals·2009
7-preclinical
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.
PMID 19267183·J Neurooncol·2009
8-other
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.
PMID 18559968·Neuro Oncol·2008
6-review
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.
PMID 18316473·Neuro Oncol·2008
3-trial
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.
PMID 18314417·Neuro Oncol·2008
3-trial
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
PMID 18356283·Neuro Oncol·2008
8-other
Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain.
PMID 18450970·Endocrinology·2008
7-preclinical
Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation.
PMID 18317690·J Neurooncol·2008
7-preclinical
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma.
PMID 18581057·J Neurooncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 25825 VERMONT AVE
HARBOR CITY, CA 90710 - Phone
- (310) 325-5111
Quick Facts
- NPI
- 1649339243
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile